CF
NYMX

Corrigan Financial’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Corrigan Financial’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-302,252
Closed -$57.4K – 79
2023
Q2 		$57.4K Hold
302,252
– – 0.02% 79
2023
Q1 		$103K Buy
+302,252
New +$123K 0.03% 76

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Corrigan Financial's NYMX Position: Q3 2023 in Review

Corrigan Financial sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 302,252 shares — an estimated $57.4K sold.

Corrigan Financial first reported a position in NYMX in Q1 2023 and held it in 2 quarters. The position peaked at $103K in Q1 2023. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Corrigan Financial reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Corrigan Financial sold 302,252 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $57.4K.
  • Corrigan Financial first reported a position in Nymox Pharmaceutical Corp in Q1 2023 and held it in 2 quarters.
  • Corrigan Financial's Nymox Pharmaceutical Corp position peaked at $103K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Corrigan Financial's 13F filing for Q3 2023, filed 16 Oct 2023.